Patents by Inventor Marc CREUS

Marc CREUS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prophylactic and Immunomodulatory Compositions and Uses
    Publication number: 20190175725
    Abstract: Provided is use of a sphingosine compound, or a derivative of a sphingosine compound, in the manufacture of a vaccine effective in the treatment and prevention of an infectious disease and treatment and/or prevention of an autoimmune disease. Also provided is use of a sphingosine compound, or a derivative of a sphingosine compound, in the manufacture of an immunomodulation medicament effective in the prevention of infectious disease and treatment and/or prevention of an autoimmune disease.
    Type: Application
    Filed: October 5, 2018
    Publication date: June 13, 2019
    Inventor: Marc Creus
  • Prophylactic and immunomodulatory compositions and uses
    Patent number: 10092643
    Abstract: Provided is use of a sphingosine compound, or a derivative of a sphingosine compound, in the manufacture of a vaccine effective in the treatment and prevention of an infectious disease and treatment and/or prevention of an autoimmune disease. Also provided is use of a sphingosine compound, or a derivative of a sphingosine compound, in the manufacture of an immunomodulation medicament effective in the prevention of infectious disease and treatment and/or prevention of an autoimmune disease.
    Type: Grant
    Filed: June 30, 2006
    Date of Patent: October 9, 2018
    Inventor: Marc Creus
  • PROPHYLACTIC AND IMMUNOMODULATORY COMPOSITIONS AND USES
    Publication number: 20100278903
    Abstract: Provided is use of a sphingosine compound, or a derivative of a sphingosine compound, in the manufacture of a vaccine effective in the treatment and prevention of an infectious disease and treatment and/or prevention of an autoimmune disease. Also provided is use of a sphingosine compound, or a derivative of a sphingosine compound, in the manufacture of an immunomodulation medicament effective in the prevention of infectious disease and treatment and/or prevention of an autoimmune disease.
    Type: Application
    Filed: June 30, 2006
    Publication date: November 4, 2010
    Applicant: KHERION TECHNOLOGY LIMITED
    Inventor: Marc CREUS